| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer, Mrd | SVP, Diagnostics, Clonoseq
1 company
Bobulsky Susan is a Chief Commercial Officer, Mrd at Adaptive Biotechnologies Corporation. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $6.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | ADPT Adaptive Biotechnologies Corporation | Chief Commercial Officer, Mrd | Sell | 41,338 | $13.17 | $544,421.46 | -8.8% | - | - | |
| Mar 5, 2025 | ADPT Adaptive Biotechnologies Corp | Chief Commercial Officer, Mrd | Sell | 26,023 | $6.98 | $181,640.54 | -7.0% | +23.8% | +98.3% | |
| Mar 5, 2024 | ADPT Adaptive Biotechnologies Corp | Chief Commercial Officer, Mrd | Sell | 12,991 | $3.44 | $44,628.88 | -2.5% | -12.4% | +112.4% | |
| Dec 10, 2020 | ADPT Adaptive Biotechnologies Corp | SVP, Diagnostics, Clonoseq | Sale+OE | 25,000 | $55.00 | $1,375,000.00 | -100% | - | - | |
| Sep 29, 2020 | ADPT Adaptive Biotechnologies Corp | SVP, Diagnostics, Clonoseq | Sale+OE | 10,000 | $50.00 | $500,000.00 | -100% | - | - |